C1q/TNF-Related Protein 9 Promotes Revascularization in Response to Ischemia
CTRP9
angiogenesis
eNOS
endothelial cell
ischemia
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
05
06
2020
accepted:
07
08
2020
entrez:
25
9
2020
pubmed:
26
9
2020
medline:
26
9
2020
Statut:
epublish
Résumé
Strategies to promote revascularization are valuable for ischemic cardiovascular disease. Although C1q/TNF-related protein (CTRP) 9 is an adiponectin paralog with protective properties against cardiometabolic disorders, the role of endogenous CTRP9 in endothelial function is largely unknown. This study aimed to investigate the effects of CTRP9 on revascularization processes and dissected the potential mechanisms. CTRP9-knockout (KO) and wild-type (WT) mice were subjected to unilateral hindlimb ischemic surgery. CTRP9-KO mice exhibited impaired blood flow recovery and decreased capillary density in the ischemic limb compared with WT mice. In both CTRP9-KO and WT mice, systemic delivery of an adenoviral vector expressing CTRP9 (Ad-CTRP9) accelerated blood flow recovery. Treatment with recombinant CTRP9 protein increased network formation and migration of cultured human umbilical vein endothelial cells (HUVECs). CTRP9 promoted the phosphorylation of AMP-activated kinase (AMPK), Akt, and endothelial nitric oxide synthase (eNOS) in HUVECs. CTRP9-KO mice also showed reduced phosphorylation levels of AMPK, Akt, and eNOS in the ischemic limbs compared with WT mice. Furthermore, blockade of AMPK or Akt signaling pathway reversed the CTRP9-stimulated eNOS phosphorylation in HUVECs. Treatment with the NOS inhibitor significantly reduced CTRP9-stimulated network formation and migration of HUVECs. Of note, Ad-CTRP9 had no effects on blood flow of the ischemic limb in eNOS-KO mice. These results indicated that CTRP9 promotes endothelial cell function and ischemia-induced revascularization through the eNOS-dependent mechanism, suggesting that CTRP9 represents a target molecule for treatment of ischemic vascular diseases.
Identifiants
pubmed: 32973529
doi: 10.3389/fphar.2020.01313
pmc: PMC7472599
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1313Informations de copyright
Copyright © 2020 Yamaguchi, Shibata, Ohashi, Enomoto, Ogawa, Otaka, Hiramatsu-Ito, Masutomi, Kawanishi, Murohara and Ouchi.
Références
Basic Res Cardiol. 2013 Jan;108(1):315
pubmed: 23212557
J Biol Chem. 2009 Jan 16;284(3):1718-24
pubmed: 18990685
J Biol Chem. 2012 Jan 2;287(1):408-17
pubmed: 22081609
Mol Cell Biochem. 2019 May;455(1-2):99-108
pubmed: 30426302
Circ Res. 2015 Apr 24;116(9):1509-26
pubmed: 25908725
Circulation. 2012 Jun 26;125(25):3066-8
pubmed: 22653085
J Cardiol. 2017 Oct;70(4):329-334
pubmed: 28325521
Am J Physiol Regul Integr Comp Physiol. 2013 Sep;305(5):R522-33
pubmed: 23842676
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2616-23
pubmed: 21836066
Arterioscler Thromb Vasc Biol. 2009 Jan;29(1):61-6
pubmed: 18974384
J Clin Invest. 2000 Aug;106(4):493-9
pubmed: 10953024
Circ J. 2012;76(7):1750-60
pubmed: 22498564
J Clin Invest. 1998 Jun 1;101(11):2567-78
pubmed: 9616228
FASEB J. 2013 Jan;27(1):25-33
pubmed: 22972916
Cytotherapy. 2014 Feb;16(2):245-57
pubmed: 24438903
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10999-1004
pubmed: 16043715
Circ Res. 2002 Jun 28;90(12):1243-50
pubmed: 12089061
J Cardiovasc Pharmacol. 2016 May;67(5):394-401
pubmed: 26814361
J Biol Chem. 2012 Jun 1;287(23):18965-73
pubmed: 22514273
J Biol Chem. 2004 Jan 9;279(2):1304-9
pubmed: 14557259
Circulation. 2017 Nov 28;136(22):2162-2177
pubmed: 28978553
Biochem Biophys Res Commun. 2016 Sep 2;477(4):685-691
pubmed: 27349872
Pharmacol Ther. 2006 Nov;112(2):553-63
pubmed: 16950515
Mol Cell Biol. 2015 Jun;35(12):2173-85
pubmed: 25870106
Int J Mol Sci. 2017 May 26;18(6):
pubmed: 28587104
Circ Res. 2013 Apr 26;112(9):1288-302
pubmed: 23620237
FASEB J. 2009 Jan;23(1):241-58
pubmed: 18787108
Nature. 1999 Jun 10;399(6736):597-601
pubmed: 10376602